breast cancer burden in eu-27
Post on 21-Oct-2021
3 Views
Preview:
TRANSCRIPT
1 in 7
new CASeS OF BreASt CAnCer per 100,000 women*
DeAthS CAuSeD By BreASt CAnCerper 100,000 women*
2020 new cases (incidence) and deaths (mortality) estimates
100.0 - 118.8118.8 - 137.6
137.6 - 156.4156.4 - 175.2
175.2 - 194.0
23.8 - 28.928.9 - 34.0
34.0 - 39.139.1 - 44.2
44.2 - 49.3
*Age-standardised rate (European new) per 100,000 *Age-standardised rate (European new) per 100,000
Breast cancer burden in EU-27
Source: ECIS – European Cancer Information System
https://ecis.jrc.ec.europa.eu accessed 15/10/2020
©European Union, 2020
355,457 91,826
Breast cancer is a malignant tumour that has developed from cells in the breast. It usually begins either in the cells of the lobules (the milk-producing glands) or in the ducts that drain the milk from the lobules to the nipple. Less commonly, breast cancer can begin in the stromal tissues, which include the fatty and fibrous connective tissues of the breast.
It is estimated that breast cancer accounts for 13.3% of all new cancer cases diagnosed in EU-27 countries in 2020. This makes it the most frequently occuring cancer. It is estimated that it accounts for 28.7% of all new cancers in women.
lifetime risk (ages 0-74) of developing breast cancer
newcases deaths
JointResearchCentre
100
50
150
200
Year
Incidence – all ages, per 100,000 women
2000
1994
1995
1996
1997
1998
1999
2001
2002
2003
2004
2005
200620
0720
0820
0920
1020
1120
1220
1320
1420
0019
9419
9519
9619
9719
9819
9920
0120
0220
0320
0420
0520
0620
0720
0820
0920
1020
1120
1220
1320
14
250
•Breast cancer is estimated to be the most diagnosed tumour among all cancer types and the first cause of cancer death among women in 2020.
•Estimated breast cancer incidence and mortality rates in 2020 vary two-fold across EU-27.
•Incidence trends in the EU-27 are mainly increasing. Multiple factors explain these changes, including reproductive factors, increasing obesity and physical inactivity as well as increased screening intensity.
•Mortality trends in the EU-27 tend to be in decline. This is mainly due to effective treatment and tools for detecting the disease at early stages.
•The five-year survival of breast cancer patients diagnosed in 2000-2007 is highest in Northern and Western Europe and lowest in Eastern Europe. National differences can in part be explained by varying levels of healthcare expenditure and resulting quality of diagnosis and treatment.
Year
tempOrAl trenDS – SeleCteD exAmpleS FrOm eurOpeAn COuntrIeS AnD regIOnS
BreASt CAnCer SurVIVAlAges >15, cancers diagnosed in 2000-2007Percentage of patients who survived at least 5 years after diagnosis
eStImAteD DIStrIButIOn OF new CASeS OF BreASt CAnCer In 2020 – By Age grOup
The Netherlands IT RomagnaDenmark DenmarkSlovenia The NetherlandsBulgaria Czech Republic
Finland FranceSweden
Italy
Belgium
Germany
The Netherlands
Spain
IrelandSlovenia
Slovakia
Estonia
Poland
Portugal
AustriaDenmarkMalta
Czech Republic
Croatia
Bulgaria
LithuaniaLatvia
Grateful acknowledgement is given to the European cancer registries as the data source for the indicators reported in the
european Cancer Information System (eCIS).
This factsheet reports information from ECIS.
For details, please visit: https://ecis.jrc.ec.europa.eu
or scan this QR code:
https://cancer-code-europe.iarc.fr
In collaboration with IARC, IACR, and EUROCARE
mortality – all ages, per 100,000 women
Age-
stan
dard
ised
rate
(Eur
opea
n st
anda
rd p
opu-
latio
n, 20
13) —
new
cas
es p
er 1
00,0
00 w
omen
Age-
stan
dard
ised
rate
(Eur
opea
n st
anda
rd p
opu-
latio
n, 20
13) —
new
cas
es p
er 1
00,0
00 w
omen
30
40
50
60
20
70
The examples (one from each European region: Central and Eastern, Northern, Southern, Western) are selected from available incidence and mortality time series of at least 20 years, from the ECIS web application (https://ecis.jrc.ec.europa.eu)
9 cases0-19 20-44 45-69 70+
191,955 cases 122,880 cases40,613 cases
hIghlIghtS
top related